Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Galileo Research
Vecchiano, PI, Italygalileoresearch.it ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Galileo Research is a non-clinical CRO with over 30 years of experience in GLP-compliant studies. It provides toxicology, biocompatibility, efficacy/performance, and mechanism-of-action studies for drugs, medical devices, food supplements, and cosmetics to support regulatory submissions. The company does not have its own clinical pipeline but has contributed to the development of bisphosphonates such as clodronate and alendronate through its historical roots.
- Therapeutic areas
- OncologyRheumatologyNeurology
- Modalities
- Small moleculeBiologicAdvanced therapy (including cell and gene therapies)Medical device testing
- Industry
- Drug Discovery Services
02
Partnerships
No major pharmaceutical or biotech partnerships publicly listed; historically linked to Abiogen Pharma.
Beyond the preview
Go deeper on Galileo Research.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Galileo Research.